These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 31145699)
1. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. Charidemou E; Ashmore T; Li X; McNally BD; West JA; Liggi S; Harvey M; Orford E; Griffin JL JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31145699 [TBL] [Abstract][Full Text] [Related]
2. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015 [TBL] [Abstract][Full Text] [Related]
4. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690 [TBL] [Abstract][Full Text] [Related]
5. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Rabøl R; Petersen KF; Dufour S; Flannery C; Shulman GI Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13705-9. PubMed ID: 21808028 [TBL] [Abstract][Full Text] [Related]
6. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease. Park H; Liu Y; Kim HS; Shin JH Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781 [TBL] [Abstract][Full Text] [Related]
7. Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes. Liu Y; Lin H; Jiang L; Shang Q; Yin L; Lin JD; Wu WS; Rui L J Clin Invest; 2020 Jun; 130(6):2992-3004. PubMed ID: 32365055 [TBL] [Abstract][Full Text] [Related]
8. The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. Lutz SZ; Hennige AM; Peter A; Kovarova M; Totsikas C; Machann J; Kröber SM; Sperl B; Schleicher E; Schick F; Heni M; Ullrich A; Häring HU; Stefan N J Clin Endocrinol Metab; 2019 Jun; 104(6):2041-2053. PubMed ID: 30541128 [TBL] [Abstract][Full Text] [Related]
9. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628 [TBL] [Abstract][Full Text] [Related]
10. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Crescenzo R; Bianco F; Falcone I; Coppola P; Liverini G; Iossa S Eur J Nutr; 2013 Mar; 52(2):537-45. PubMed ID: 22543624 [TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver. Surugihalli C; Muralidaran V; Ryan CE; Patel K; Zhao D; Sunny NE Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E299-E313. PubMed ID: 36791321 [TBL] [Abstract][Full Text] [Related]
12. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Roumans KHM; Lindeboom L; Veeraiah P; Remie CME; Phielix E; Havekes B; Bruls YMH; Brouwers MCGJ; Ståhlman M; Alssema M; Peters HPF; de Mutsert R; Staels B; Taskinen MR; Borén J; Schrauwen P; Schrauwen-Hinderling VB Nat Commun; 2020 Apr; 11(1):1891. PubMed ID: 32312974 [TBL] [Abstract][Full Text] [Related]
13. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Softic S; Cohen DE; Kahn CR Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717 [TBL] [Abstract][Full Text] [Related]
14. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis. Okuma C; Ohta T; Tadaki H; Ishigure T; Sakata S; Taniuchi H; Sano R; Hamada H; Kume S; Nishiu J; Kakutani M J Pharmacol Sci; 2015 Jul; 128(3):150-7. PubMed ID: 26215699 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347 [TBL] [Abstract][Full Text] [Related]